MedTrace Logo

Allo BMT in Advanced Leukemia or High Grade Lymphoma

NCT00186290 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 145

Last updated 2010-10-11

No results posted yet for this study

Summary

To evaluate the role of ablative allogeneic hematopoietic cell transplantation in the treatment of advanced leukemia or lymphoma.

Conditions

  • Lymphoma, Non-Hodgkin
  • Leukemia
  • Blood and Marrow Transplant (BMT)
  • Lymphomas: Non-Hodgkin

Interventions

PROCEDURE

ablative allogeneic hematopoietic cell transplantation

Sponsors & Collaborators

Principal Investigators

  • Robert Lowsky · Stanford University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1989-12-31
Primary Completion
2009-10-31
Completion
2009-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00186290 on ClinicalTrials.gov